Mumbai, 30th June: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapsone Gel, 5%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Aczone Gel, 5%, of Almirall, LLC. Dapsone Gel is…
AHMEDABAD, 18 NOVEMBER: AstraZeneca Pharma: Company partners with Sun Pharma to help patients living with Hyperkalaemia in India (Positive) PTC Industries: Company Announces Expansion of Gujarat Facility, Company Expansion to Add Over 50,000 Sq Ft of Shop Floor Area (Positive) Aayush Wellness: Strategic Partnership with Blinkit to Strengthen Its Distribution Network (Positive) WPIL: Company Unit…
AHMEDABAD,10th September: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Phytonadione Injectable Emulsion…
